Article

Quantifying Uncertainty and Robustness in a Biomathematical Model Based Patient-Specific Response Metric for Glioblastoma

2018-05-17

Abstract excerpt

Glioblastomas, lethal primary brain tumors, are known for their heterogeneity and invasiveness. A growing literature has been developed demonstrating the clinical relevance of a biomathematical model, the Proliferation-Invasion (PI) model, of glioblastoma growth. Of interest here is the development of a treatment response metric, Days Gained (DG). This metric is based on individual tumor kinetics estimated through...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7f4f840a-5b28-5595-9b02-f56db6fe9221
DOI: 10.1101/325340

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Quantifying Uncertainty and Robustness in a Biomathematical Model Based Patient-Specific Response Metric for GlioblastomaDOI 10.1101/325340Read

Patient-specific mathematical neuro-oncology: using a simple proliferation and invasion tumor model to inform clinical practice.Semantic proximity Read

Personalized Glioblastoma Multiforme Growth Modeling by Integrating Clinical Genomic and Phenotypic DataSemantic proximity Read

Towards Image - Based Personalization of Glioblastoma Therapy A Clinical and Biological Validation Study of a Novel, Deep Learning - Driven Tumor Growth ModelSemantic proximity Read

Uncertainty Quantification in Radiogenomics: EGFR Amplification in GlioblastomaSemantic proximity Read

A revised mathematical model of pre-diagnostic glioma growth incorporating vascularization and tumor mutational burdenSemantic proximity Read

Diagnosing Growth in Low-Grade Gliomas with and Without AI-Measured Longitudinal Volume Measurements: A Retrospective Observational StudySemantic proximity Read

Segmentation Uncertainty Estimation as a Sanity Check for Image Biomarker StudiesSemantic proximity Read

In Vitro/In Silico Study on the Role of Doubling Time Heterogeneity among Primary Glioblastoma Cell LinesSemantic proximity Read

Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade GliomaSemantic proximity Read

Comparing Methods for Uncertainty Estimation of Paraganglioma Growth PredictionsSemantic proximity Read

Assessing radiological response of IDH-mutated glioma to vorasidenib by tumor diameter slopes: a series of 8 cases.Semantic proximity Read

Estimating intratumoral heterogeneity from spatiotemporal data.Semantic proximity Read